Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 1.00 |
| ▸ | LIMK1 | P53667 | 1/20 | 1.00 |
| ▸ | CDK5 | Q00535 | 1/20 | 1.00 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 1.00 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.66 |
| ▸ | NPBWR1 | P48145 | 11/20 | 0.64 |
| ▸ | RAB9A | P51151 | 9/20 | 0.64 |
| ▸ | NPC1 | O15118 | 8/20 | 0.64 |
| ▸ | MAPT | P10636 | 7/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.64 |
| ▸ | HTT | P42858 | 4/20 | 0.63 |
| ▸ | CASP3 | P42574 | 2/20 | 0.63 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.63 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.63 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.63 |
| ▸ | MMP2 | P08253 | 1/20 | 0.63 |
| ▸ | MMP9 | P14780 | 1/20 | 0.63 |
| ▸ | MMP8 | P22894 | 1/20 | 0.63 |
| ▸ | MMP13 | P45452 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 4/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2243690 | 0.90 | CHEK1 (0.81) | CHEK1LIMK1CDK5CLK4P2RY6 | |
| SCHEMBL29545885 | 0.84 | CHEK1 (0.72) | CHEK1LIMK1CDK5CLK4P2RY6 | |
| SCHEMBL1171437 | 0.83 | NPC1 (0.82) | CHEK1LIMK1CDK5CLK4NPBWR1 | |
| SCHEMBL20982761 | 0.79 | NPC1 (0.97) | NPBWR1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL8603371 | 0.79 | ALOX5 (0.73) | CHEK1LIMK1CDK5CLK4P2RY6 | |
| SCHEMBL31679090 | 0.78 | NPBWR1 (1.00) | NPBWR1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL2245102 | 0.78 | NPBWR1 (1.00) | NPBWR1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL5566191 | 0.77 | NPC1 (1.00) | NPBWR1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL20982700 | 0.77 | NPC1 (0.94) | NPBWR1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL31357765 | 0.77 | RAB9A (1.00) | NPBWR1RAB9ANPC1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180317484-A1 | COMPOSITION FOR INHIBITING SYNTHESIS OF MYCOTOXIN WITHOUT AFFECTING THE GROWTH OF THE FUNGI | VIT UNIVERSITY (IN) | 2018-11-08 | — | — | US | claimed |
| US-20180317484-A1 | COMPOSITION FOR INHIBITING SYNTHESIS OF MYCOTOXIN WITHOUT AFFECTING THE GROWTH OF THE FUNGI | VIT UNIVERSITY (IN) | 2018-11-08 | — | — | US | disclosed |
| US-4716168-A | STIMULANTS OF IMMUNE RESPONSE | NORWICH EATON PHARMACEUTICALS, INC. (US) | 1987-12-29 | — | — | US | disclosed |
| EP-0187705-A2 | Imidazo(4,5-f)quinolines useful as immunomodulating agents | Norwich Eaton Pharmaceuticals, Inc. (US) | 1986-07-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180317484-A1 | COMPOSITION FOR INHIBITING SYNTHESIS OF MYCOTOXIN WITHOUT AFFECTING THE GROWTH OF THE FUNGI | NAT1, AKR7A2, CYC1 | CHEK1 1668/4885LIMK1 4664/4885CDK5 1619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.